Vancouver, B.C., December 5, 2017 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) MYM has completed a financing to raise funds to be used to further extend working capital for general and administrative and operations commitments.  The company is committed to becoming a global leader in cannabis production and keeping stakeholders informed of its progress. The funds raised pursuant to the financing are specifically targeted for the communications program. As such, the company continues to maintain the cash it has on hand for its production facility projects. The financing consists of 240,000 common shares at a price of $2.50.

Since August 31, 2017, the Company has issued 6,403,333 shares for the exercise of Warrants for gross proceeds of $1,267,283.20.

The issuance of securities described in this news release is subject to acceptance by the Canadian Securities Exchange. All amounts quoted in this news release are in Canadian funds

About MYM

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products.  To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.  MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD

Rob Gietl, CEO
MYM Nutraceuticals Inc.
www.mymarijuana.ca

Investor Relations
Terry Brown
1-855-696-2261
1-778-522-2261 Direct